GPC2-CAR T cell therapy
/ Stanford University
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 04, 2025
GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults
(clinicaltrials.gov)
- P1 | N=18 | Recruiting | Sponsor: Stanford University | Not yet recruiting ➔ Recruiting
Enrollment open • Brain Cancer • Embryonal Tumor • Medulloblastoma • Neuroblastoma • Oncology • Pediatrics • Pineoblastoma • Rhabdoid Tumor • Sarcoma • Solid Tumor
1 to 1
Of
1
Go to page
1